ATLANTA, May 18, 2015 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced a change in the Company's presentation time at this week's UBS Global Healthcare Conference in New York.
Dan Myers, President and Chief Executive Officer, will now be presenting on Tuesday, May 19, 2015 at 10:00 a.m. ET. The presentation will be webcast live and will be available for access, along with the slides that will be used for the presentation, on the Investor Relations section of the corporate website at www.alimerasciences.com. For those who are not available to listen to the live broadcast, the webcast will be archived for 90 days.
About Alimera Sciences, Inc.
Alimera Sciences, Inc., headquartered in Alpharetta, Georgia, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera's European operations are conducted from London by its subsidiary, Alimera Sciences Limited, which has offices in Aldershot, U.K., Berlin, Germany and Lisbon, Portugal.
SOURCE Alimera Sciences, Inc.